KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Short term Debt (2016 - 2025)

Amgen (AMGN) has 14 years of Short term Debt data on record, last reported at $4.6 billion in Q4 2025.

  • For Q4 2025, Short term Debt rose 29.55% year-over-year to $4.6 billion; the TTM value through Dec 2025 reached $4.6 billion, up 29.55%, while the annual FY2025 figure was $4.6 billion, 29.55% up from the prior year.
  • Short term Debt reached $4.6 billion in Q4 2025 per AMGN's latest filing, up from $2.2 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $5.5 billion in Q2 2024 and bottomed at $87.0 million in Q4 2021.
  • Average Short term Debt over 5 years is $2.6 billion, with a median of $2.3 billion recorded in 2025.
  • Peak YoY movement for Short term Debt: surged 4651.65% in 2021, then tumbled 81.11% in 2022.
  • A 5-year view of Short term Debt shows it stood at $87.0 million in 2021, then surged by 1728.74% to $1.6 billion in 2022, then decreased by 9.3% to $1.4 billion in 2023, then soared by 146.02% to $3.6 billion in 2024, then increased by 29.55% to $4.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $4.6 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.4 billion in Q2 2025.